Anthony E. Rizzardi

Neuroscience · Life Sciences

14h-index1.1kcitations55works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nerve injury and regeneration(15), Glioma Diagnosis and Treatment(8), PI3K/AKT/mTOR signaling in cancer(8), Prostate Cancer Treatment and Research(6), Neurofibromatosis and Schwannoma Cases(5)

Publications55 total

Supplementary Table and Figure Legends from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 1 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table and Figure Legends from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Data from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 4 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table 1 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Materials from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Supplementary Figure 1 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 4 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Materials from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Supplementary Figure 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Data from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Data from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 3 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Data from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Supplementary Figure 3 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table 1 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Stephen C. Schmechel(49), Aaron L. Sarver(27), David A. Largaespada(26), Eric P. Rahrmann(24), Branden S. Moriarity(24), Colleen L. Forster(23), Adrienne L. Watson(17), Nancy Ratner(17), Kwangmin Choi(16), Margaret H. Collins(16), Margaret R. Wallace(16), Caitlin B. Conboy(15), Andrew D. Greeley(15), Amanda L. Halfond(15), Leah K. Anderson(15), Brian R. Wahl(15), Vincent W. Keng(15), Jonathan C. Henriksen(11), Yunqian Pan(11), Kevin M. Regan(11)